UTAH MEDICAL PRODUCTS INC
Close on Oct 19, 2026
- Market cap
- $237.37M
- P/E (TTM)
- 22.7
- Dividend yield
- –
About Utah Medical Products
Surgical & Medical Instruments & Apparatus, SIC 3841
Utah Medical Products, Inc. manufactures and markets specialized medical devices designed to improve patient safety and clinical outcomes. The company's products span critical care sectors, including labor and delivery, neonatal intensive care, and gynecology, electrosurgery, and urology. Offerings include fetal monitoring accessories, intrauterine pressure catheters, vacuum-assisted delivery systems, infant respiratory hoods, enteral feeding devices, and electrosurgical systems such as loop electrodes and generators. Its customers primarily consist of clinical end-user facilities, hospitals, outpatient clinics, and physician offices, alongside designated stocking distributors and medical device companies utilizing subcontract manufacturing.
The company operates manufacturing and distribution facilities across the United States, Ireland, the United Kingdom, Canada, Australia, and New Zealand. Outside the United States, products reach end-users directly and through approximately 200 independent distributors across major developed and developing markets worldwide. Utah Medical Products, Inc. maintains its corporate headquarters in Midvale, Utah.
Summary of the business section of Utah Medical Products's latest annual report, written by StockData.
Company profile
Company
- Legal name
- UTAH MEDICAL PRODUCTS INC
- Founded
- 1978
- Headquarters
- Midvale, UT
- Address
- 7043 S 300 West 84070
- Phone
- (801) 521-5301
- Website
- utahmed.com
- Employees
- 140, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Utah
- Fiscal year ends
- December 31
- Auditor
- Haynie & Company, Salt Lake City, Utah
Stock & identifiers
- Ticker
- UTMD
- Exchange
- Nasdaq
- Shares outstanding
- 3M, Aug 11, 2026
- Public float
- $168.20M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 706698
- CUSIP
- 917488108
- ISIN
- US9174881089
- LEI
- 5493002R27BBGV8DID60
- EIN
- 87-0342734
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Brian Koopman | Principal Financial Officer | 782 |
| Paul O. Richins | Director | 43,144 |
| Kevin Timken | Director | – |
| Carrie Leigh | Director | 51 |
Employees
Headcount reported in annual reports
“At December 31, 2025, the Company worldwide had 140 full-time employees, 12 part-time employees, 7 regular consultants, 15 independent sales representatives and 9 outside (non-employee) directors of UTMD or its subsidiaries.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 25, 2024 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 25, 2024 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Feb 13, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 16, 2018 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Mar 23, 2011 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 28, 2006 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Dec 16, 1996 | Listing | Registration of securities on an exchange (Form 8-A) |